Predict your next investment

HEALTHCARE | Drug Discovery
formatherapeutics.com

See what CB Insights has to offer

Competitors

14

Business Relationships

10

Service Providers

4

FORMA Therapeutics Competitors & Alternatives

14 Competitors

FORMA Therapeutics has 14 competitors. FORMA Therapeutics's competitors are Cognition Therapeutics, Five Prime Therapeutics, CellCentric, Nuevolution, Prosarix and more.

Latest Funding

Companies

Investment Stage

Total Funding

Mosaic
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

Location

10/8/2021

IPO

$77.3M

Pennsylvania

4/16/2021

Acq - P2P

$75M

California

10/27/2020

Series E

$73.9M

United Kingdom

7/8/2019

Acq - P2P

$33.8M

Denmark

2/6/2019

Acquired - II

United Kingdom

2/11/2016

Proteostasis Therapeutics

IPO

$122.6M

Massachusetts

7/8/2014

Peakdale Molecular

Acquired

United Kingdom

5/18/2012

Cellzome

Acquired

Germany

7/21/2011

Astex Pharmaceuticals (acquired by SuperGen)

Acquired

United Kingdom

12/14/2009

Therasis

Series A

$12M

New York

Latest Funding

10/8/2021

4/16/2021

10/27/2020

7/8/2019

2/6/2019

2/11/2016

7/8/2014

5/18/2012

7/21/2011

12/14/2009

Companies

Proteostasis Therapeutics

Peakdale Molecular

Cellzome

Astex Pharmaceuticals (acquired by SuperGen)

Therasis

Investment Stage

IPO

Acq - P2P

Series E

Acq - P2P

Acquired - II

IPO

Acquired

Acquired

Acquired

Series A

Total Funding

$77.3M

$75M

$73.9M

$33.8M

$122.6M

$12M

Mosaic

Location

Pennsylvania

California

United Kingdom

Denmark

United Kingdom

Massachusetts

United Kingdom

Germany

United Kingdom

New York

FORMA Therapeutics Service Providers

4 Service Providers

FORMA Therapeutics has 4 service provider relationships

Service Provider

Associated Rounds

Provider Type

Service Type

IPO

Investment Bank

Bookrunner

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Service Provider

Subscribe to see more

Subscribe to see more

Associated Rounds

IPO

Subscribe to see more

Provider Type

Investment Bank

Subscribe to see more

Subscribe to see more

Service Type

Bookrunner

Subscribe to see more

Partnership data by VentureSource

FORMA Therapeutics Partners & Customers

10 Partners and customers

FORMA Therapeutics has 10 strategic partners and customers. FORMA Therapeutics recently partnered with HitGen on May 5, 2018.

Date

Type

Business Partner

Country

News Snippet

Sources

5/31/2018

Partner

HitGen

China

FORMA Therapeutics and HitGen Initiate Multiyear Research Collaboration

`` Our partnership with FORMA Therapeutics is a confirmation of HitGen Ltd. 's platform expertise and uniquely structured business partnerships tailored to meet the needs of our collaborators .

3

3/26/2018

Partner

Arpeggio Biosciences

United States

FORMA Therapeutics Collaborates with Arpeggio Biosciences to Explore Translational Utility of Drug Candidates

FORMA Therapeutics and Arpeggio Biosciences today announced a collaboration to utilize Arpeggio Biosciences ' proprietary technology to supplement FORMA Therapeutics 's analysis of the biological effects of its potential drug candidates .

4

6/17/2015

Partner

Boehringer Ingelheim

Germany

FORMA Therapeutics : Announces Achievement of Multiple Collaboration Milestones with Boehringer Ingelheim for Modulating Protein-Protein Interactions

FORMA Therapeutics announced today the achievement of several discovery milestones in their alliance with Boehringer Ingelheim for the discovery of novel drug candidates against protein-protein interactions for the treatment of cancer .

4

12/8/2014

Partner

Zobio, and Domainex

Netherlands, and United Kingdom

Subscribe to see more

Subscribe to see more

10

9/23/2014

Partner

Moffitt Cancer Center

United States

Subscribe to see more

Subscribe to see more

10

Date

5/31/2018

3/26/2018

6/17/2015

12/8/2014

9/23/2014

Type

Partner

Partner

Partner

Partner

Partner

Business Partner

HitGen

Arpeggio Biosciences

Boehringer Ingelheim

Zobio, and Domainex

Moffitt Cancer Center

Country

China

United States

Germany

Netherlands, and United Kingdom

United States

News Snippet

FORMA Therapeutics and HitGen Initiate Multiyear Research Collaboration

`` Our partnership with FORMA Therapeutics is a confirmation of HitGen Ltd. 's platform expertise and uniquely structured business partnerships tailored to meet the needs of our collaborators .

FORMA Therapeutics Collaborates with Arpeggio Biosciences to Explore Translational Utility of Drug Candidates

FORMA Therapeutics and Arpeggio Biosciences today announced a collaboration to utilize Arpeggio Biosciences ' proprietary technology to supplement FORMA Therapeutics 's analysis of the biological effects of its potential drug candidates .

FORMA Therapeutics : Announces Achievement of Multiple Collaboration Milestones with Boehringer Ingelheim for Modulating Protein-Protein Interactions

FORMA Therapeutics announced today the achievement of several discovery milestones in their alliance with Boehringer Ingelheim for the discovery of novel drug candidates against protein-protein interactions for the treatment of cancer .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

3

4

4

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.